Boston Scientific (BSX) Increases Despite Market Slip: Here's What You Need to Know

Group 1 - Boston Scientific (BSX) closed at $102.27, with a +0.32% change from the previous day, outperforming the S&P 500's daily loss of 1.46% [1] - The stock has increased by 12.44% over the past month, leading the Medical sector's gain of 1.84% and the S&P 500's gain of 1.08% [1] Group 2 - Boston Scientific is set to release its earnings report on February 5, 2025, with an expected EPS of$ 0.65, reflecting an 18.18% increase from the prior-year quarter [2] - The consensus estimate anticipates revenue of $4.4 billion, indicating an 18.13% increase from the same quarter last year [2] Group 3 - Recent adjustments to analyst estimates for Boston Scientific are important, as they reflect short-term business trends and analyst optimism about the company's profitability [3] - Positive estimate revisions can lead to near-term stock movements, which investors can capitalize on using the Zacks Rank system [4] Group 4 - The Zacks Rank system ranges from 1 (Strong Buy) to 5 (Strong Sell), with 1 stocks averaging an annual return of +25% since 1988 [5] - Currently, Boston Scientific holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate having moved 0.1% lower in the past month [5] Group 5 - Boston Scientific has a Forward P/E ratio of 36.8, which is higher than the industry average Forward P/E of 19.01, indicating it is trading at a premium [6] - The company has a PEG ratio of 2.67, compared to the Medical - Products industry's average PEG ratio of 2.15 [7] Group 6 - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 93, placing it in the top 38% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]